I am pleased to share with you members of the Fierce JPM Week 2021 speaking faculty. To view this email as a web page,
click here | | Dear E, I am pleased to announce our latest round of speakers for Fierce JPM Week 2021 – a three-day virtual event running January 11–13, 2021. Join speakers from Moderna, Genentech, AlloVir, Roche, AstraZeneca and more for a series of CEO interviews and panel discussions exploring biopharma's ongoing work to combat COVID-19 – and to fight the world's other diseases at the same time. With a strong focus on networking, this year's virtual platform will allow you to facilitate one-to-one video meetings and group chats with speakers, partners, and attendees. | |
|
|
| | | Stéphane Bancel
Moderna
CEO | | Alexander Hardy
Genentech
CEO | | Daphne Koller
insitro
CEO and Founder |
|---|
|
| |
|
|
| | | Ann Leen, Ph.D.
AlloVir
Chief Scientific Officer | | Levi Garraway, M.D., Ph.D.
Roche and Genentech
Chief Medical Officer | | Ruud Dobber
AstraZeneca
EVP and President, BioPharmaceuticals Business Unit |
|---|
|
| |
|
|
| | Thank You to Our Sponsors | |
|
|
| | | You are currently subscribed as newsletter@newslettercollector.com
If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe.
Refer to our Privacy Policy.
Fierce LifeSciences is a division of Questex LLC.
685 3rd Ave 21st Floor New York, NY 10017
© 2020 Questex LLC. All Rights Reserved.
Reproduction in whole or in part is prohibited without written permission. |
| |
|
|
